In their letter published in the January 9, 2006, issue of the ARCHIVES, Mascitelli and Pezzetta1 state that thiazolidinedione use has been shown to decrease hip and femoral neck bone mineral density (BMD)2 and suggest that this is an explanation for our report that adults with type 2 diabetes mellitus are at higher fracture risk compared with adults without diabetes in the Health, Aging, and Body Composition (Health ABC) Study.3 While we agree that thiazolidinedione use may be associated with bone loss, the prevalence of thiazolidinedione use was too low to account for the increased fracture risk associated with type 2 diabetes mellitus that we reported.3 The reference that Mascitelli and Pezzetta1 cite is also from the Health ABC Study,2 and only 11 (2%) of 566 participants with diabetes in our report used a thiazolidinedione at the start of the study in 1997-1998. In the first 4 years of the study during which our fracture outcomes were collected, only 69 (12%) of 566 participants with diabetes used a thiazolidinedione.4 Our analyses of diabetes and fracture risk considered baseline BMD to adjust for differences among thiazolidinedione users.3 In addition, although not included our report, we found a similar prevalence of thiazolidinedione use among participants with diabetes who did and did not experience a fracture. In a recently published abstract,4 we noted that there were modest losses in total hip BMD associated with longer duration of thiazolidinedione use during the first 4 years of the study, although it is an unlikely explanation for our findings given the low prevalence of thiazolidinedione users over this time. Furthermore, several cohort studies conducted prior to the introduction of thiazolidinedione use have found an association between type 2 diabetes mellitus and incident fracture risk,5- 6 suggesting that other aspects of diabetes are risk factors for fracture. As more participants with diabetes are exposed to thiazolidinedione use over time, it may be possible to determine if there is a specific effect on fracture that is independent of diabetes.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Purchase Online Access to this article for 24 hours
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and
Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early
dhildhood mortality and growth failure data and their association with maternal
Thank you for submitting a comment on this article. It will be reviewed by JAMA Internal Medicine editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 1
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Users' Guides to the Medical Literature
Example 1: Diabetes and Target Blood Pressure
Users' Guides to the Medical Literature
For example, researchers who conducted a randomized trial of a diabetes education program...
All results at
and access these and other features:
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.